A Study of a Topical Patch (AB001) in Patients With Chronic Low Back Pain
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to examine the safety, tolerability, and efficacy of
repeated topical administration of AB001 topical patches for the treatment of chronic low
back pain.
Phase:
Phase 2
Details
Lead Sponsor:
Frontier Biotechnologies Co., Ltd. Frontier Biotechnologies Inc.